Left ventricular assist device options in pediatric patients

R. C. Ashton, M. C. Oz, Robert E. Michler, G. Champsaur, K. A. Catanese, Daphne T. Hsu, L. J. Addonizio, J. M. Quaegebeur

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Left ventricular assist devices can be successfully used in the pediatric population if currently available devices are used appropriately. To highlight their management strategies, the authors' experience with pediatric left ventricular assist devices is reviewed, with case studies documenting options for device use. A retrospective study was conducted for all patients supported at the authors' institutions. Nine pediatric patients received devices during this time, with ages ranging from 12 days to 15 years. There was considerable size differences in our patients, with weights ranging between 2.5 and 73 kg. Either the Abiomed BVS 5000 (Abiomed Cardiovascular, Inc, Danvers, MA) or the Biomedicus centrifugal pump (Bio-Medicus, Inc, Eden Prairie, MN) were used for all patients. Patients were supported for an average of 5 days (range 1-11 days). Eight patients were successfully weaned from the device, with four undergoing transplant. Four patients were discharged and are long-term survivors, and one is still recovering post transplant. Neurologic sequelae were the most common complications in these patients, with four patients having events. Pediatric ventricular assist devices are limited because of size considerations, although current devices can be successfully used for bridging to recovery or transplantation. New devices are needed to meet the flow and size characteristics for pediatric patients. Successful use of assist devices, as has been recognized in adults, is possible in pediatric patients if these requirements are met.

Original languageEnglish (US)
JournalASAIO Journal
Volume41
Issue number3
StatePublished - 1995
Externally publishedYes

Fingerprint

Left ventricular assist devices
Pediatrics
Heart-Assist Devices
Transplants
Equipment and Supplies
Centrifugal pumps
Recovery
Nervous System
Survivors

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering

Cite this

Ashton, R. C., Oz, M. C., Michler, R. E., Champsaur, G., Catanese, K. A., Hsu, D. T., ... Quaegebeur, J. M. (1995). Left ventricular assist device options in pediatric patients. ASAIO Journal, 41(3).

Left ventricular assist device options in pediatric patients. / Ashton, R. C.; Oz, M. C.; Michler, Robert E.; Champsaur, G.; Catanese, K. A.; Hsu, Daphne T.; Addonizio, L. J.; Quaegebeur, J. M.

In: ASAIO Journal, Vol. 41, No. 3, 1995.

Research output: Contribution to journalArticle

Ashton, RC, Oz, MC, Michler, RE, Champsaur, G, Catanese, KA, Hsu, DT, Addonizio, LJ & Quaegebeur, JM 1995, 'Left ventricular assist device options in pediatric patients', ASAIO Journal, vol. 41, no. 3.
Ashton RC, Oz MC, Michler RE, Champsaur G, Catanese KA, Hsu DT et al. Left ventricular assist device options in pediatric patients. ASAIO Journal. 1995;41(3).
Ashton, R. C. ; Oz, M. C. ; Michler, Robert E. ; Champsaur, G. ; Catanese, K. A. ; Hsu, Daphne T. ; Addonizio, L. J. ; Quaegebeur, J. M. / Left ventricular assist device options in pediatric patients. In: ASAIO Journal. 1995 ; Vol. 41, No. 3.
@article{58d35b95ed5a414f8709cccf655401c8,
title = "Left ventricular assist device options in pediatric patients",
abstract = "Left ventricular assist devices can be successfully used in the pediatric population if currently available devices are used appropriately. To highlight their management strategies, the authors' experience with pediatric left ventricular assist devices is reviewed, with case studies documenting options for device use. A retrospective study was conducted for all patients supported at the authors' institutions. Nine pediatric patients received devices during this time, with ages ranging from 12 days to 15 years. There was considerable size differences in our patients, with weights ranging between 2.5 and 73 kg. Either the Abiomed BVS 5000 (Abiomed Cardiovascular, Inc, Danvers, MA) or the Biomedicus centrifugal pump (Bio-Medicus, Inc, Eden Prairie, MN) were used for all patients. Patients were supported for an average of 5 days (range 1-11 days). Eight patients were successfully weaned from the device, with four undergoing transplant. Four patients were discharged and are long-term survivors, and one is still recovering post transplant. Neurologic sequelae were the most common complications in these patients, with four patients having events. Pediatric ventricular assist devices are limited because of size considerations, although current devices can be successfully used for bridging to recovery or transplantation. New devices are needed to meet the flow and size characteristics for pediatric patients. Successful use of assist devices, as has been recognized in adults, is possible in pediatric patients if these requirements are met.",
author = "Ashton, {R. C.} and Oz, {M. C.} and Michler, {Robert E.} and G. Champsaur and Catanese, {K. A.} and Hsu, {Daphne T.} and Addonizio, {L. J.} and Quaegebeur, {J. M.}",
year = "1995",
language = "English (US)",
volume = "41",
journal = "ASAIO journal (American Society for Artificial Internal Organs : 1992)",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Left ventricular assist device options in pediatric patients

AU - Ashton, R. C.

AU - Oz, M. C.

AU - Michler, Robert E.

AU - Champsaur, G.

AU - Catanese, K. A.

AU - Hsu, Daphne T.

AU - Addonizio, L. J.

AU - Quaegebeur, J. M.

PY - 1995

Y1 - 1995

N2 - Left ventricular assist devices can be successfully used in the pediatric population if currently available devices are used appropriately. To highlight their management strategies, the authors' experience with pediatric left ventricular assist devices is reviewed, with case studies documenting options for device use. A retrospective study was conducted for all patients supported at the authors' institutions. Nine pediatric patients received devices during this time, with ages ranging from 12 days to 15 years. There was considerable size differences in our patients, with weights ranging between 2.5 and 73 kg. Either the Abiomed BVS 5000 (Abiomed Cardiovascular, Inc, Danvers, MA) or the Biomedicus centrifugal pump (Bio-Medicus, Inc, Eden Prairie, MN) were used for all patients. Patients were supported for an average of 5 days (range 1-11 days). Eight patients were successfully weaned from the device, with four undergoing transplant. Four patients were discharged and are long-term survivors, and one is still recovering post transplant. Neurologic sequelae were the most common complications in these patients, with four patients having events. Pediatric ventricular assist devices are limited because of size considerations, although current devices can be successfully used for bridging to recovery or transplantation. New devices are needed to meet the flow and size characteristics for pediatric patients. Successful use of assist devices, as has been recognized in adults, is possible in pediatric patients if these requirements are met.

AB - Left ventricular assist devices can be successfully used in the pediatric population if currently available devices are used appropriately. To highlight their management strategies, the authors' experience with pediatric left ventricular assist devices is reviewed, with case studies documenting options for device use. A retrospective study was conducted for all patients supported at the authors' institutions. Nine pediatric patients received devices during this time, with ages ranging from 12 days to 15 years. There was considerable size differences in our patients, with weights ranging between 2.5 and 73 kg. Either the Abiomed BVS 5000 (Abiomed Cardiovascular, Inc, Danvers, MA) or the Biomedicus centrifugal pump (Bio-Medicus, Inc, Eden Prairie, MN) were used for all patients. Patients were supported for an average of 5 days (range 1-11 days). Eight patients were successfully weaned from the device, with four undergoing transplant. Four patients were discharged and are long-term survivors, and one is still recovering post transplant. Neurologic sequelae were the most common complications in these patients, with four patients having events. Pediatric ventricular assist devices are limited because of size considerations, although current devices can be successfully used for bridging to recovery or transplantation. New devices are needed to meet the flow and size characteristics for pediatric patients. Successful use of assist devices, as has been recognized in adults, is possible in pediatric patients if these requirements are met.

UR - http://www.scopus.com/inward/record.url?scp=0028828366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028828366&partnerID=8YFLogxK

M3 - Article

VL - 41

JO - ASAIO journal (American Society for Artificial Internal Organs : 1992)

JF - ASAIO journal (American Society for Artificial Internal Organs : 1992)

SN - 1058-2916

IS - 3

ER -